ONLINE DATABASE SEARCH - HIV-LS-338-MEMO
1. 48289 HIV-LS-338; PUBMED-HIV-12/27/2005
New targets and new drugs in the treatment of HIV
Lopez-Aldeguer, J, Aguirrebengoa, K, Arribas, JR, Este, JA, and Kindelan, JM
Enferm Infecc Microbiol Clin 2005. 23(Supl.2): 33-40
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16373002&dopt=abstract
2. 48290 HIV-LS-338; PUBMED-HIV-12/27/2005
Anti-HIV activity against immunodeficiency virus type 1 (HIV-I) and type II (HIV-II) of compounds isolated from the stem bark of Combtetum molle
Asres, K and Bucar, F
Ethiop Med J 2005. 43(1): 15-20
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16370525&dopt=abstract
3. 48291 HIV-LS-338; PUBMED-HIV-12/27/2005
Anti-HIV-1 activities of extracts from the medicinal plant Rhus chinensis
Wang, RR, Gu, Q, Yang, LM, Chen, JJ, Li, SY, and Zheng, YT
J Ethnopharmacol 2005.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16368204&dopt=abstract
4. 48292 HIV-LS-338; EMBASE-HIV-12/27/2005
Fenretinide inhibits HIV infection by promoting viral endocytosis
Finnegan, Catherine M and Blumenthal, Robert
Antiviral Research 2005. In Press, Uncorrected Proof
HYPERLINK:
http://www.sciencedirect.com/science/article/B6T2H-4HS3GFC-1/2/e5ad704e9048f26ff1b11c3cc1e18eaf
5. 48293 HIV-LS-338; PUBMED-HIV-12/27/2005
Synthesis and antiviral evaluation of novel 4'-hydroxymethyl branched thioapiosyl nucleosides
Kim, JW and Hong, JH
Arch Pharm (Weinheim) 2005. 338(12): 577-81
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16353276&dopt=abstract
6. 48294 HIV-LS-338; EMBASE-HIV-12/27/2005
Identification of N-phenyl-N'-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4
Zhao, Qian, Ma, Liying, Jiang, Shibo, Lu, Hong, Liu, Shuwen, He, Yuxian, Strick, Nathan, Neamati, Nouri, and Debnath, Asim Kumar
Virology 2005. 339(2): 213-225
HYPERLINK:
http://www.sciencedirect.com/science/article/B6WXR-4GJK858-3/2/99ccdb511ff38fc3085fe98209ac277d
7. 48295 HIV-LS-338; PUBMED-HIV-12/27/2005
Structural Analysis of Silanediols as Transition-State-Analogue Inhibitors of the Benchmark Metalloprotease Thermolysin(,)
Juers, DH, Kim, J, Matthews, BW, and Sieburth, SM
Biochemistry 2005. 44(50): 16524-16528
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16342943&dopt=abstract
8. 48296 HIV-LS-338; PUBMED-HIV-12/27/2005
Diketo Acid Pharmacophore. 2. Discovery of Structurally Diverse Inhibitors of HIV-1 Integrase
Dayam, R, Sanchez, T, and Neamati, N
J Med Chem 2005. 48(25): 8009-15
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16335925&dopt=abstract
9. 48297 HIV-LS-338; PUBMED-HIV-12/27/2005
Parallel Solution-Phase and Microwave-Assisted Synthesis of New S-DABO Derivatives Endowed with Subnanomolar Anti-HIV-1 Activity
Manetti, F, Este, JA, Clotet-Codina, I, Armand-Ugon, M, Maga, G, Crespan, E, Cancio, R, Mugnaini, C, Bernardini, C, Togninelli, A, Carmi, C, Alongi, M, Petricci, E, Massa, S, Corelli, F, and Botta, M
J Med Chem 2005. 48(25): 8000-8008
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16335924&dopt=abstract
10. 48298 HIV-LS-338; PUBMED-HIV-12/27/2005
Different Stereochemical Requirements for CXCR4 Binding and Signaling Functions As Revealed by an Anti-HIV, d-Amino Acid-Containing SMM-Chemokine Ligand
Dong, CZ, Kumar, S, Choi, WT, Madani, N, Tian, S, An, J, Sodroski, JG, and Huang, Z
J Med Chem 2005. 48(25): 7923-7924
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16335916&dopt=abstract
11. 48299 HIV-LS-338; PUBMED-HIV-12/27/2005
Evaluation of a neural networks QSAR method based on ligand representation using substituent descriptors Application to HIV-1 protease inhibitors
Milac, AL, Avram, S, and Petrescu, AJ
J Mol Graph Model 2005.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16325439&dopt=abstract
12. 48300 HIV-LS-338; PUBMED-HIV-12/27/2005
Emtricitabine, a new antiretroviral agent with activity against HIV and hepatitis B virus
Saag, MS
Clin Infect Dis 2006. 42(1): 126-31
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16323102&dopt=abstract
13. 48301 HIV-LS-338; PUBMED-HIV-12/27/2005
Effects of Diterpenes Isolated from the Brazilian Marine Alga Dictyota menstrualis on HIV-1 Reverse Transcriptase
Pereira, Hde S, Leao-Ferreira, LR, Moussatche, N, Teixeira, VL, Cavalcanti, DN, da, Costa LJ, Diaz, R, and Frugulhetti, IC
Planta Med 2005. 71(11): 1019-24
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16320202&dopt=abstract
14. 48302 HIV-LS-338; PUBMED-HIV-12/27/2005
A beta-galactose-specific lectin isolated from the marine worm Chaetopterus variopedatus possesses anti-HIV-1 activity
Wang, JH, Kong, J, Li, W, Molchanova, V, Chikalovets, I, Belogortseva, N, Luk'yanov, P, and Zheng, YT
Comp Biochem Physiol C Toxicol Pharmacol 2005.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16316787&dopt=abstract
15. 48303 HIV-LS-338; WOS-HIV-12/18/2005
Structure-activity relationship studies on CXCR4 antagonists having cyclic pentapeptide scaffolds
Tamamura, H, Esaka, A, Ogawa, T, Araki, T, Ueda, S, Wang, ZX, Trent, JO, Tsutsumi, H, Masuno, H, Nakashima, H, Yamamoto, N, Peiper, SC, Otaka, A, and Fujii, N
ORGANIC & BIOMOLECULAR CHEMISTRY 2005. 3(24): 4392-4394, 3
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000233721500014
16. 48304 HIV-LS-338; WOS-HIV-12/18/2005
HIV-1 drug resistance in Thailand: Before and after National Access to Antiretroviral Program
Sutthent, R, Arworn, D, Kaoriangudom, S, Chokphaibulkit, K, Chaisilwatana, P, Wirachsilp, P, Thiamchai, V, Sirapraphasiri, T, and Tanprasertsuk, S
JOURNAL OF CLINICAL VIROLOGY 2005. 34(4): 272-276, 5
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000233769700006
17. 48305 HIV-LS-338; WOS-HIV-12/18/2005
Carbohydrate-binding agents cause deletions of highly conserved glycosylation sites in HIV GP120 - A new therapeutic concept to hit the Achilles heel of HIV
Balzarini, J, Van, Laethem K, Hatse, S , Froeyen, M, Peumans, W, Van Damme, E, and Schols, D
JOURNAL OF BIOLOGICAL CHEMISTRY 2005. 280(49): 41005-41014, 10
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000233666600075
18. 48306 HIV-LS-338; WOS-HIV-12/18/2005
Bioengineering lactic acid bacteria to secrete the HIV-1 virucide cyanovirin
Pusch, O, Boden, D, Hannify, S, Lee, F, Tucker, LD, Boyd, MR, Wells, JM, and Ramratnam, B
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES 2005. 40(5): 512-520, 9
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000233694600002
19. 48307 HIV-LS-338; WOS-HIV-12/18/2005
Synthesis of hydantoin, thiohydantoin and desulphuration of thiohydantoin to hydantoin
Dubey, VS
ASIAN JOURNAL OF CHEMISTRY 2006. 18(1): 155-158, 4
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000233608100023
20. 48308 HIV-LS-338; WOS-HIV-12/18/2005
Inhibition of human immunodeficiency virus type 1 reverse transcriptase, RNase H, and integrase activities by hydroxytropolones
Didierjean, J, Isel, C, Querre, F, Mouscadet, JF, Aubertin, AM, Valnot, JY, Piettre, SR, and Marquet, R
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 2005. 49(12): 4884-4894, 11
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000233692100008